Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCP2 | P22307 | 1/20 | 0.75 |
| ▸ | GPR84 | Q9NQS5 | 10/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL60937 | 0.94 | SCP2 (0.72) | SCP2GPR84MEN1NPC1POLB | |
| SCHEMBL13182638 | 0.94 | SCP2 (0.72) | SCP2GPR84MEN1NPC1POLB | |
| SCHEMBL13201656 | 0.92 | SCP2 (0.76) | SCP2GPR84MEN1NPC1POLB | |
| SCHEMBL14267417 | 0.85 | SCP2 (1.00) | SCP2GPR84MEN1NPC1POLB | |
| SCHEMBL13930776 | 0.85 | SCP2 (0.66) | SCP2GPR84MEN1NPC1POLB | |
| SCHEMBL26434988 | 0.85 | SCP2 (0.75) | SCP2GPR84MEN1NPC1POLB | |
| SCHEMBL62370 | 0.85 | SCP2 (0.77) | SCP2GPR84MEN1NPC1POLB | |
| SCHEMBL19646592 | 0.85 | SCP2 (0.77) | SCP2GPR84MEN1NPC1POLB | |
| SCHEMBL26434823 | 0.84 | SCP2 (0.76) | SCP2GPR84MEN1NPC1POLB | |
| SCHEMBL3501312 | 0.84 | SCP2 (0.82) | SCP2GPR84MEN1NPC1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129525-B2 | Long wavelength thiol-reactive fluorophores | BECTON DICKINSON AND COMPANY (US) | 2012-03-06 | — | — | US | disclosed |
| US-8071794-B2 | Long wavelength thiol-reactive fluorophores | BECTON, DICKINSON AND COMPANY (US) | 2011-12-06 | — | — | US | disclosed |
| US-20110184168-A1 | LONG WAVELENGTH THIOL-REACTIVE FLUOROPHORES | BECTON, DICKINSON AND COMPANY (US) | 2011-07-28 | — | — | US | disclosed |
| US-20100003763-A1 | LONG WAVELENGTH THIOL-REACTIVE FLUOROPHORES | BECTON, DICKINSON AND COMPANY (US) | 2010-01-07 | — | — | US | disclosed |
| US-7563891-B2 | Long wavelength thiol-reactive fluorophores | BECTON, DICKINSON & COMPANY (US) | 2009-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100003763-A1 | LONG WAVELENGTH THIOL-REACTIVE FLUOROPHORES | NUCB2, NDC1, NCBP1 | SCP2 2959/4885GPR84 3140/4885MEN1 4815/4885 |
| US-20110184168-A1 | LONG WAVELENGTH THIOL-REACTIVE FLUOROPHORES | NUCB2, NDC1, NCBP1 | SCP2 2959/4885GPR84 3140/4885MEN1 4815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.